Thomas Hartung

Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. The Journal of Infectious Diseases. 2023:jiad334. doi:10.1093/infdis/jiad334

Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041

David Pamies, Marcel Leist, Sandra Coecke, et al. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). Alternatives to Animal Experimentation. 2022;39(1):30-70. doi:10.14573/altex.2111011

Uwe Marx, Takafumi Akabane, Tommy B. Andersson, et al. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. ALTEX. 2020;37(3):365-394. doi:10.14573/altex.2001241

Thomas Hartung, Rob De Vries, Sebastian Hoffmann, et al. Toward Good In Vitro Reporting Standards. Alternatives to Animal Experimentation. 2019;36(1):3-17. doi:10.14573/altex.1812191

Lucy Meigs, Lena Smirnova, Costanza Rovida, Marcel Leist, Thomas Hartung. Animal testing and its alternatives - the most important omics is economics. Alternatives to Animal Experimentation. 2018;35(3):275-305. doi:10.14573/altex.1807041

David Pamies, Anna Bal-Price, Christophe Chesné, et al. Advanced Good Cell Culture Practice for human primary, stem cell-derived and organoid models as well as microphysiological systems. Alternatives to Animal Experimentation. 2018;35(3):353-378. doi:10.14573/altex.1710081

Sandra Coecke, Michael Balls, Gerard Bowe, et al. Guidance on Good Cell Culture Practice - A report of the second ECVAM task force on Good Cell Culture Practice. Alternatives to Laboratory Animals. 2005;33(3):261-287. doi:10.1177/026119290503300313